{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "Enantiomers of 4-[[(cyanoimino) [(1,2,2-trimethylpropyl)amino]methyl]amino]benzonitrile", "item": "https://www.patentleaderboard.com/patent/6262122"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Enantiomers of 4-[[(cyanoimino) [(1,2,2-trimethylpropyl)amino]methyl]amino]benzonitrile

Enantiomers of 4-[[(cyanoimino) [(1,2,2-trimethylpropyl)amino]methyl]amino]benzonitrile

US Patent 6262122 · Granted Jul 17, 2001

Estimated economic value: $126,224,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antibodies specific for epidermal growth factor receptor variant III and their u2022
Chimeric antigen receptors targeting epidermal growth factor receptor variant II2022
Chimeric antigen receptors targeting epidermal growth factor receptor variant II2019
Antibodies specific for epidermal growth factor receptor variant III and their u2019
Stable emulsion formulations2014
Hydrate forms of AMG7062011
Heterocyclic compounds as sweetener enhancers2010
Heterocyclic dihydropyrimidine compounds2009
Heterocyclic sodium/proton exchange inhibitors and method2008
Heterocyclic dihydropyrimidine compounds2007
(1-phenyl-2-heteoaryl)ethyl-guanidine compounds as inhibitors of mitochondrial F2005
Heterocyclic sodium/proton exchange inhibitors and method2005